No Data
No Data
Shanghai InnoStar Bio-tech Opens 60% Above IPO Price
Express News | Shanghai Innostar Bio-Tech Says Trading in Shares to Debut on Sept 3 in Shanghai
Yinuo Si (688710.SH): will be listed on the STAR Market on September 3rd.
Yinuosi (688710.SH) announced that the company's stocks will be traded on the Shanghai Stock Exchange on September 3, 2024...
This state-owned enterprise succeeded in IPO relying on "monkey"!
The STAR Market is about to welcome a new listing. According to UBS, Yinosi (688710.SH) completed its subscription on August 23rd and will be listed on the STAR Market soon. Haitong Securities is the sponsoring institution. Yinosi is a biomedical CRO company, ranking third in market share in the domestic non-clinical safety evaluation segment, behind Wuxi AppTec and Joinn Laboratories. When it comes to CXOs, many investors will think of Glan as their first reaction. The ups and downs of the CXO industry in recent years have left many people feeling regretful. Everyone involved in it cannot escape the industry's cycles. Yinosi has experienced high growth in the industry's wave.
Yinuo Si (688710.SH): After the callback, the final online subscription rate is 0.0486%.
YinuoSi (688710.SH) announced that after the recall mechanism was activated, the final number of offline issuances was 1691....
A-share subscription | Yinosi (688710.SH) starts subscription, ranking the top three in the domestic non-clinical safety evaluation subdivision market share.
On August 23rd, Yinuosi (688710.SH) started the subscription, with an issue price of 19.06 yuan per share and a maximum subscription limit of 0.008 million shares, with a PE ratio of 15.4 times. It belongs to the STAR Market of the Shanghai Stock Exchange, with Haitong Securities as the sponsor and lead underwriter.
No Data
No Data